Recent News

• 06.02.2025 - Catalyst Pharmaceuticals Announces Appointment of William T. Andrews, MD, FACP as Chief Medical Officer
• 06.02.2025 - Catalyst Pharmaceuticals Announces Appointment of William T. Andrews, MD, FACP as Chief Medical Officer
• 06.02.2025 - Catalyst Pharmaceuticals Announces Appointment of William T. Andrews, MD, FACP as Chief Medical Officer
• 05.14.2025 - BofA Securities Health Care Conference 2025
• 05.14.2025 - BofA Securities Health Care Conference 2025
• 05.08.2025 - Catalyst Pharmaceuticals First Quarter 2025 Financial Results
• 05.08.2025 - Catalyst Pharmaceuticals First Quarter 2025 Financial Results
• 05.08.2025 - Catalyst Pharmaceuticals First Quarter 2025 Financial Results
• 05.08.2025 - Catalyst Pharmaceuticals First Quarter 2025 Financial Results
• 05.07.2025 - Catalyst Pharmaceuticals Reports Record First Quarter 2025 Financial Results and Provides Business Update

Recent Filings

• 06.02.2025 - EX-99.1 EX-99.1
• 06.02.2025 - 144 Report of proposed sale of securities
• 06.02.2025 - 8-K Current report
• 05.30.2025 - 144 Report of proposed sale of securities
• 05.30.2025 - 144 Report of proposed sale of securities
• 05.23.2025 - 8-K Current report
• 05.15.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.14.2025 - 144 Report of proposed sale of securities
• 05.13.2025 - 144 Report of proposed sale of securities